Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.190,01
0,28%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Nevro Corp (NVRO) Nevro Corp (NVRO) Notizie

Nevro Corp

NVRO
9,03
-0,22 (-2,38%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/6/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:15PRNUSNevro to Present at Truist Securities MedTech Conference
30/5/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202422:21EDGAR2Form 8-K - Current report
29/5/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:15PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
17/5/202422:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/5/202422:52EDGAR2Form 8-K - Current report
09/5/202422:05PRNUSNevro to Present at BofA Securities 2024 Healthcare..
07/5/202422:56EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:11EDGAR2Form 8-K - Current report
07/5/202422:05PRNUSNevro Reports First-Quarter 2024 Financial Results
17/4/202414:30PRNUSNevro to Report First-Quarter 2024 Financial Results and..
11/3/202421:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:10PRNUSNevro Receives FDA 510(k) Clearance to Use SI Fixation..
23/2/202423:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/2/202422:11EDGAR2Form 8-K - Current report
21/2/202422:09EDGAR2Form 8-K - Current report
21/2/202422:06PRNUSNevro Enters Into Cooperation Agreement With Engaged Capital
21/2/202422:05PRNUSNevro Reports Fourth-Quarter and Full-Year 2023 Financial..
14/2/202421:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202421:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202422:30PRNUSNevro Announces Consensus Statement Supporting..
29/1/202422:30PRNUSNevro to Report Fourth-Quarter and Full-Year 2023 Financial..
18/1/202422:15PRNUSNevro Announces Positive Coverage Update from Carelon..
17/1/202422:15PRNUSNevro to Highlight 25 Scientific Abstracts at 2024 North..
11/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
10/1/202423:26EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/1/202414:41EDGAR2Form 8-K - Current report
09/1/202414:30PRNUSNevro Announces Preliminary Fourth-Quarter and Full-Year..
08/1/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:15PRNUSNevro to Present at 42nd Annual J.P. Morgan Healthcare..
Apertura: 9,06 Min: 8,985 Max: 9,345
Chiusura: 9,25

La tua Cronologia

NYSE
NVRO
Nevro
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network